US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
RLAY holding history
Relay Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RLAY overviewAll 13F holders of RLAYFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,258
- Value
- $98.4K
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,258 | $98.4K | <0.1% | +26+0.5% | Added | Holders |
| Q1 2026 | 5,232 | $52.1K | <0.1% | +101+2.0% | Added | Holders |
| Q4 2025 | 5,131 | $43.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 5,131 | $26.8K | <0.1% | −354−6.5% | Reduced | Holders |
| Q2 2025 | 5,485 | $19.0K | <0.1% | +4,208+329.5% | Added | Holders |
| Q1 2025 | 1,277 | $3.35K | <0.1% | −2,534−66.5% | Reduced | Holders |
| Q4 2024 | 3,811 | $15.7K | <0.1% | +2,746+257.8% | Added | Holders |
| Q3 2024 | 1,065 | $7.54K | <0.1% | −840−44.1% | Reduced | Holders |
| Q2 2024 | 1,905 | $12.4K | <0.1% | +227+13.5% | Added | Holders |
| Q1 2024 | 1,678 | $13.9K | <0.1% | −150−8.2% | Reduced | Holders |
| Q4 2023 | 1,828 | $20.1K | <0.1% | +1,828 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −129−100.0% | Sold out | Holders |
| Q2 2023 | 129 | $1.62K | <0.1% | +93+258.3% | Added | Holders |
| Q1 2023 | 36 | $593 | <0.1% | +36 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −266−100.0% | Sold out | Holders |
| Q3 2022 | 266 | $6.00K | <0.1% | +266 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −235−100.0% | Sold out | Holders |
| Q1 2022 | 235 | $7.00K | <0.1% | +235 | New | Holders |